Microscopic polyangiitis presenting with liver dysfunction preceding rapidly progressive necrotizing glomerulonephritis

Southern Medical Journal

Volumn 97, Issue 9, 2004, Pages 911-914

  Takebayashi, Kohzo ^a   Aso, Yoshimasa ^b   Kitamura, Hiroshi ^b   Sakurai, Yusei ^b   Wakabayashi, Sadao ^b   Inukai, Toshihiko ^b  

^a DOKKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Liver dysfunction; Microscopic polyangiitis; Perinuclear antineutrophil cytoplasmic antibody

Indexed keywords

METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; STEROID;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; FATIGUE; FEMALE; FEVER; HEADACHE; HUMAN; HUMAN TISSUE; LIVER DYSFUNCTION; LIVER FUNCTION TEST; MEDICAL EXAMINATION; MICROSCOPIC POLYANGIITIS; RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS; STEROID THERAPY; SYSTEMIC VASCULITIS; TREATMENT OUTCOME;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; FEMALE; GLOMERULONEPHRITIS; HUMANS; LIVER DISEASES; LIVER FUNCTION TESTS; MIDDLE AGED; NECROSIS; VASCULITIS;

EID: 4544310493     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.SMJ.0000105082.08745.67     Document Type: Article

References (15)

1. Davson J, Ball J, Platt R. The kidney in periarteritis nodosa. Q J Med 1948;17:175.
2. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-192.
3. Hauschild S, Schmitt WH, Csemok E, et al. ANCA in systemic vasculitides, collagen vascular diseases, rheumatic disorders and inflammatory bowel diseases. Adv Exp Med Biol 1993;336:245-251.
4. Davenport A, Lock RJ, Wallington TB, et al. Clinical significance of anti-neutrophil cytoplasm antibodies detected by a standardized indirect immunofluorescence assay. Q J Med 1994;87:291-299.
5. Adu D, Pall A, Luqmani RA, et al. Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. Q J Med 1997;90:401-409.
6. Guillevin L, Durand-Gasselin B, Cevallos R, et al. Microscopic polyangiitis: Clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999;42:421-430.
7. D'Agati V, Chander P, Nash M, et al. Idiopathic microscopic polyarteritis nodosa: Ultrastructural observations on the renal vascular and glomerular lesions. Am J Kidney Dis 1986;7:95-110.
8. Savage CO, Winearls CG, Evans DJ, et al. Microscopic polyarteritis: Presentation, pathology and prognosis. Q J Med 1985;56:467-483.
9. Adu D, Howie AJ, Scott DG, et al. Polyarteritis and the kidney. Q J Med 1987;62:221-237.
10. Targan SR, Landers C, Vidrich A, et al. High-titer antineutrophil cytoplasmic antibodies in type-I autoimmune hepatitis. Gastroenterology 1995;108:1159-1166.
11. Duerr RH, Targan SR, Landers CJ, et al. Neutrophil cytoplasmic antibodies: A link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 1991;100:1385-1391.
12. Mulder AH, Horst G, Haagsma EB, et al. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases. Hepatology, 1993;17:411-417.
13. Lesavre P, Noel LH, Gayno S, et al. Atypical autoantigen targets of perinuclear antineutrophil cytoplasm antibodies (P-ANCA): Specificity and clinical associations. J Autoimmun 1993;6:185-195.
14. Goritsas CP, Repanti M, Papadaki E, et al. Intrahepatic bile duct injury and nodular regenerative hyperplasia of the liver in a patient with polyarteritis nodosa. J Hepatol 1997;26:727-730.
15. Nakamoto T, Yoshikawa M, Nakatani T, et al. Microscopic polyangiitis that presented liver dysfunction prior to noted renal manifestations. Intern Med 2000;39:517-521.